You searched for "lymphomas"
Association of dry eye symptoms in patients with dyslipidaemia and statin use
1 August 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
Meibomian gland dysfunction, dyslipidaemia, hypercholesterolaemia, lipid, statin
This retrospective analysis of the Blue Mountains Eye Study III cohort (Caucasian Australians residing west of Sydney n=1680; mean age >74 years, range 60-97) analysed the association between dyslipidaemia, use of oral statins and symptoms of dry disease (DED) among...
Smartphone use and its effects on eyes
Longitudinal pilot study on 12 young healthy adults comparing effects of smartphone use over a 60-minute period. Reading conditions and smartphone use was standardised for all participants. Ocular symptoms, tear function and binocular vision were assessed before and after each...
Natural history of idiopathic intracranial hypertension depending on incidental or symptomatic presentation
3 February 2023
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a large retrospective review cohort of consecutive patients diagnosed or presumed idiopathic intracranial hypertension (IIH) over a three-year period at a single tertiary centre. Patients on medication with a known aetiology for IIH were excluded. The cohort...
Visual snow syndrome: a review
11 January 2024
| Ivan Yip
|
EYE - Neuro-ophthalmology
Visual snow syndrome (VSS) is a neurological condition characterised by visual phenomena described as dots moving across the visual field. Other visual symptoms can take the form of palinopsia, entopic phenomena, photophobia and nyctalopia. Tinnitus and migraine can be commonly...
Survey reveals poor public awareness of dry eye disease
17 May 2021
A new survey has revealed how few people are aware of Dry Eye Disease, a debilitating and painful eye condition which affects one in four people in the UK.
Measuring patient-reported outcomes after refractive surgery to assess patient satisfaction
Patient-reported outcomes enable surgeons to evaluate patients’ symptoms and satisfaction after laser vision correction. The great majority of patients are pleased with their outcomes from laser vision correction, whether it is with photorefractive keratectomy, laser in-situ keratomileusis (LASIK), or small...
Long-term meibomian gland function following a single thermal pulsation treatment
1 December 2013
| Kwesi Amissah-Arthur
|
EYE - Cornea, EYE - General
|
LipiFlow thermal pulsation system, dry eye, meibomian gland dysfunction
Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...
Rebamipide 2% for dry eye
Rebamipide is a quinolinone derivative that has been found to increase mucin production and the number of conjunctival goblet cells. A previous phase two study has shown rebamipide 2% to be better than placebo in improving the ocular surface and...Blind Football Fan ‘Scores’ Support
25 January 2024
|
ECLO, RNIB, sight loss, patient stories, AMD, Age-related macular degeneration (AMD)
A Ross County supporter has praised the club and leading sight loss charity, RNIB Scotland, for helping him to keep attending games.
SOS (Simplified Ophthalmic Statistics) Part 4: How to present your statistical analysis
1 October 2019
| Catey Bunce, Tafadzwa Young-Zvandasara
|
EYE - General
This is the last in this series of short guides which we hope provide some guidance in relation to statistical issues researchers may encounter when conducting research, audit or indeed quality improvement projects. Here we focus on an issue that...
Herpes zoster ophthalmicus: a clinician’s perspective
25 January 2023
| Anitha Priya Arun Shankar, A. R. Reddy
|
EYE - General
Introduction Herpes zoster, commonly known as shingles, is caused by the reactivation of varicella zoster virus (VZV). The term herpes is derived from a Greek work, herpein, which means ‘creeping’ and the word zoster means a belt or a girdle...
Rituximab as an immunosuppression treatment for thyroid eye disease
1 October 2015
| Claire Howard
|
EYE - Neuro-ophthalmology
Thyroid eye disease is traditionally treated with high dose glucocorticosteroids and surgical orbital decompression, where responses are often inadequate. This medical treatment is centred around symptom control and reduction of thyroid hormone synthesis, not immunosuppression. Rituximab is an anti-CD20 monoclonal...
